Jump Financial »

Lineage Cell Therapeutics In shares owned by Jump Financial

Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Jump Financial from 13F filings

Historical chart of Jump Financial investment in Lineage Cell Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Lineage Cell Therapeutics In held by Jump Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lineage Cell Therapeutics In by Jump Financial

Quarter filed Position value Share count Share price at filing
2026-03-31 $57k 36k 1.58
2025-06-30 $28k 31k 0.91
2024-03-31 $108k 73k 1.48

More positions owned by Jump Financial

iShares Russell 2000 ETF Etf (IWM)
Invesco QQQ Trust Series 1 Etf Call Option (QQQ)
State Street SPDR S&P 500 ETF Trust Etf Call Option (SPY)
iShares iBoxx USD High Yield Corporate Bond ETF Etf Call Option (HYG)
State Street Energy Select Sector SPDR ETF Etf (XLE)
Super Micro Computer Convertible bond (Principal)
iShares Core S&P 500 ETF Etf (IVV)
iShares 20 Year Treasury Bond ETF Etf Call Option (TLT)
State Street Consumer Discretionary Select Sector SPDR ETF Etf (XLY)
iShares Silver Trust Etf (SLV)
Direxion Daily Semiconductor Bull 3X ETF Etf (SOXL)
CME Group Common Stock (CME)
Sandisk Corp Common Stock (SNDK)
Microsoft Corp Common Stock (MSFT)
Alibaba Group Holding Convertible bond (Principal)

View all positions for Jump Financial

Top funds holding Lineage Cell Therapeutics In

Broadwood Capital
Vanguard Capital Management
Defender Capital
Millennium Management
Raffles Associates
Fifth Third Bancorp
BlackRock
Armistice Capital
Marshall Wace
Geode Capital Management
Renaissance Technologies
Morgan Stanley
Susquehanna International
UBS Group
Vanguard Fiduciary Trust

View all funds holding Lineage Cell Therapeutics In